Literature DB >> 28676507

Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis - Position Paper for ISPD: 2017 Update.

Edwina A Brown1, Joanne Bargman2, Wim van Biesen3, Ming-Yang Chang4, Frederic O Finkelstein5, Helen Hurst6, David W Johnson7, Hideki Kawanishi8, Mark Lambie9, Thyago Proença de Moraes10, Johann Morelle11, Graham Woodrow12.   

Abstract

Entities:  

Keywords:  Peritoneal dialysis; encapsulating peritoneal sclerosis; membrane transport; shared decision-making; ultrafiltration

Mesh：

Year:  2017        PMID： 28676507     DOI： 10.3747/pdi.2017.00018

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  28 in total

Review 1.  Encapsulating peritoneal sclerosis.

Authors:  Christopher J Danford; Steven C Lin; Martin P Smith; Jacqueline L Wolf
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 2.  Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis.

Authors:  Laura Sola; Nathan W Levin; David W Johnson; Roberto Pecoits-Filho; Harith M Aljubori; Yuqing Chen; Stefaan Claus; Allan Collins; Brett Cullis; John Feehally; Paul N Harden; Mohamed H Hassan; Fuad Ibhais; Kamyar Kalantar-Zadeh; Adeera Levin; Abdulkarim Saleh; Daneil Schneditz; Irma Tchokhonelidze; Rumeyza Turan Kazancioglu; Ahmed Twahir; Robert Walker; Anthony J O Were; Xueqing Yu; Fredric O Finkelstein
Journal:  Kidney Int Suppl (2011)       Date:  2020-02-19

3.  Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.

Authors:  Bart Dioos; Goedele Paternot; Rose-Marie Jenvert; Annick Duponchelle; Mark R Marshall; Migaku Nakajima; Edward Ramirez Ganoza; James A Sloand; Anders P Wieslander
Journal:  Clin Exp Nephrol       Date:  2018-06-20       Impact factor: 2.801

4.  Care of the pediatric patient on chronic peritoneal dialysis.

Authors:  Annabelle N Chua; Reeti Kumar; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2022-05-19       Impact factor: 3.651

5.  Dialysis Duration and Glucose Exposure Amount Do Not Increase Mortality Risk in Peritoneal Dialysis Patients: A Population-Based Cohort Study From 2004 to 2012.

Authors:  Pei-Yu Wu; Ming-Yen Lin; Shang-Jyh Hwang; Yi-Wen Chiu
Journal:  Front Med (Lausanne)       Date:  2022-06-28

6.  Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.

Authors:  Yunmee Lho; Jun-Young Do; Jung-Yoon Heo; A-Young Kim; Sang-Woon Kim; Seok-Hui Kang
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

7.  Encapsulating Peritoneal Sclerosis after kidney Transplantation: Success of Medical Treatment.

Authors:  Hanene Gaied; Mohamed Mongi Bacha; Fatima Jaziri; Mondher Ounissi; Raja Aoudia; Mouna Jerbi; Hafedh Hedri; Rim Goucha; Taieb Benabdallah
Journal:  Indian J Nephrol       Date:  2021-04-02

8.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26

Review 9.  Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition.

Authors:  Robert B Wilson; Rami Archid; Marc A Reymond
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

Review 10.  Proteomic Research in Peritoneal Dialysis.

Authors:  Mario Bonomini; Francesc E Borras; Maribel Troya-Saborido; Laura Carreras-Planella; Lorenzo Di Liberato; Arduino Arduini
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.